Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: August 3, 2022
Reporting Period: Quarter ended June 30, 2022
Context: The filing announces the issuance of a press release containing earnings results and unaudited condensed consolidated financial statements for the second quarter of 2022.
Key Financial Metrics
The provided text serves as a cover document referencing an external press release (Exhibit 99.1) for detailed financial data. Consequently, the filing text does not provide clear values for the following metrics:
- Revenue
- Profit (Net Income/Loss)
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the incorporated press release (Exhibit 99.1) for year-over-year or quarter-over-quarter comparisons.
Guidance, Outlook, and Risks
Management Commentary: The text confirms the release of earnings but does not include specific management commentary, forward-looking guidance, or outlook statements within the 8-K body.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt. The filing notes that the information is furnished pursuant to Item 2.02 and is not deemed "filed" under Section 18 of the Exchange Act unless expressly incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and EPS figures for the quarter ended June 30, 2022.
- Verify year-over-year growth rates and margin trends in the accompanying unaudited financial statements.
- Check for any updated forward-looking guidance or operational outlook provided in the press release.
- Confirm the status of the company's emerging growth company election (indicated as checked in the filing).